Dr Reddys Laboratories (RDY) Current Taxes (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Current Taxes of $46.0 million for Q1 2026, up 31.43% year-on-year from $35.0 million in Q1 2025, and up 31.43% on a QoQ basis from $35.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Current Taxes (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories (RDY) has reported Current Taxes for 10 consecutive years, with $46.0 million the latest figure, recorded in Q1 2026.
- Quarterly Current Taxes rose 31.43% year-over-year to $46.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.0 million (up 31.43% YoY) and the FY2026 annual result came in at $46.0 million, up 31.43% from the prior year.
- Current Taxes improved to $46.0 million in Q1 2026 per RDY's latest filing, from $35.0 million in the prior quarter.
- Over the last five years, Current Taxes for RDY reached as high as $46.0 million in Q1 2026 and fell as low as $21.0 million in Q1 2022.
- A 5-year average of $31.2 million and a median of $28.0 million in 2024 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes gained 7.69% — and 2026, when it surged 31.43%.
- Year by year, Current Taxes stood at $21.0 million in 2022, then grew by 23.81% to $26.0 million in 2023, then climbed by 7.69% to $28.0 million in 2024, then rose by 25.0% to $35.0 million in 2025, then jumped by 31.43% to $46.0 million in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $46.0 million, $35.0 million, and $28.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - | 46.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Mar 31, 2024 | 28.00 Mn |
| Mar 31, 2023 | 26.00 Mn |
| Mar 31, 2022 | 21.00 Mn |
| Mar 31, 2021 | 19.00 Mn |
| Mar 31, 2020 | 8.00 Mn |
| Mar 31, 2019 | 3.00 Mn |
| Mar 31, 2018 | 23.00 Mn |
| Dec 31, 2009 | 29.00 Mn |
| Sep 30, 2009 | 27.00 Mn |
| Jun 30, 2009 | 42.00 Mn |